Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hemachandra Reddy

Showing results (111-120 of 278) with videos related to

Pageof 28
Sort By:
Neuromolecular Medicine|April 13, 2004
Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damageMaria Manczak, Byung S Park, Youngsin Jung, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 6, 2023
Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's diseaseNeha Sawant, Sudhir Kshirsagar, P Hemachandra Reddy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 11, 2019
Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's diseaseSubodh Kumar, Arubala P Reddy, Xiangling Yin, et al.
Ageing Research Reviews|July 6, 2023
Urgent needs of caregiving in ageing populations with Alzheimer's disease and other chronic conditions: Support our loved onesJohn W Culberson, Jonathan Kopel, Ujala Sehar, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2026
Behavioral consequences of serotonin deficiency in TPH2 knock-in mice: Implications for depression, anxiety, and cognitive dysfunctionMadhuri Bandaru, Alvir Rainier, Md Ariful Islam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 19, 2022
Are mitophagy enhancers therapeutic targets for Alzheimer's disease?Jangampalli Adi Pradeepkiran, Ashly Hindle, Sudhir Kshirsagar, et al.
Biochimica Et Biophysica Acta|September 24, 2013
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosisPeizhong Mao, Maria Manczak, Ulziibat P Shirendeb, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Current Status of Obesity: Protective Role of CatechinsTanisha Basu, Ashley Selman, Arubala P Reddy, et al.
Ageing Research Reviews|May 30, 2024
Unraveling the NRF2 confusion: Distinguishing nuclear respiratory factor 2 from nuclear erythroid factor 2Mathew George, Arubala P Reddy, P Hemachandra Reddy, et al.
Human Molecular Genetics|February 22, 2021
Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's diseaseArubala P Reddy, Xiangling Yin, Neha Sawant, et al.
Pageof 28

Showing results (111-120 of 278) with videos related to

Sort By:
Pageof 28
Neuromolecular Medicine|April 13, 2004
Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damageMaria Manczak, Byung S Park, Youngsin Jung, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 6, 2023
Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's diseaseNeha Sawant, Sudhir Kshirsagar, P Hemachandra Reddy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 11, 2019
Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's diseaseSubodh Kumar, Arubala P Reddy, Xiangling Yin, et al.
Ageing Research Reviews|July 6, 2023
Urgent needs of caregiving in ageing populations with Alzheimer's disease and other chronic conditions: Support our loved onesJohn W Culberson, Jonathan Kopel, Ujala Sehar, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2026
Behavioral consequences of serotonin deficiency in TPH2 knock-in mice: Implications for depression, anxiety, and cognitive dysfunctionMadhuri Bandaru, Alvir Rainier, Md Ariful Islam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 19, 2022
Are mitophagy enhancers therapeutic targets for Alzheimer's disease?Jangampalli Adi Pradeepkiran, Ashly Hindle, Sudhir Kshirsagar, et al.
Biochimica Et Biophysica Acta|September 24, 2013
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosisPeizhong Mao, Maria Manczak, Ulziibat P Shirendeb, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Current Status of Obesity: Protective Role of CatechinsTanisha Basu, Ashley Selman, Arubala P Reddy, et al.
Ageing Research Reviews|May 30, 2024
Unraveling the NRF2 confusion: Distinguishing nuclear respiratory factor 2 from nuclear erythroid factor 2Mathew George, Arubala P Reddy, P Hemachandra Reddy, et al.
Human Molecular Genetics|February 22, 2021
Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's diseaseArubala P Reddy, Xiangling Yin, Neha Sawant, et al.
Pageof 28